Name: Treatment Options for MDS with Dr. Rory Shallis by AAMDSIF Podcasts for Patients
Duration: 16 min 45 s
Description: Dr. Rory Shallis details treatment options for MDS, or Myelodysplastic Syndromes.

Dr. Jacqueline Garcia describes how hypomethylating agents are used in treatment.

Hypomenthylating Agents with Dr. Jacqueline Garcia

Dr. Rory Shallis details treatment options for MDS, or Myelodysplastic Syndromes.

Treatment Options for MDS with Dr. Rory Shallis

Older adults may have the option for a bone marrow transplant, depending on a number of factors. Listen to Dr. Nandita Khera here to learn more.

Transplant For Older Adults with Dr. Nandita Khera

Treating PNH, or paroxysmal nocturnal hemoglobinuria, continues to evolve. Learn about the latest treatments with Dr. Allysono Pishko here.

Advances in Treating PNH with Dr Allyson Pishko - 2022

Claire was a NICU nurse, so she had never experienced a pattient with Aplastic Anemia.  
Then, she became a patient herself.
Find out how she learned she was stronger than she knew in this episode.

Pediatric Nurse Finds her Way through Aplastic Anemia Treatment

Discussion of the recent approval of Luspatercept with Doctor Amit Verma, Director of the Division of Hematologic Malignancies and a Professor of Oncology at the Albert Einstein College of Medicine in New York City.  #MDS #treatingMDS

Explaining Luspatercept with Dr. Amit Verma

Dr. Abdulraheem Yacoub talks with Leigh Clark about MDS-MPNs overlap. He includes how molecular testing is used in determining treatment options.
He also discusses the newly approved drug, Luspatercept, for the treatment of MDS and MDS-MPN overlap syndromes.

Dr. Yacoub explains MDS-MPNs overlap

Dr. David Steensma discusses MDS and toxins with Leigh Clark, Patient Educator. Dr. Steensma is an associate professor at Harvard Medical School and faculty member in the leukemia program at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, Massachusetts and the Edward P. Evans Chair in MDS at Dana-Farber Cancer Institute

Dr David Steensma discusses MDS and toxins

Dr. Eunice Wang explains the origin and treatment of secondary MDS. Dr. Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Center.

Dr. Eunice Wang discusses Secondary MDS

Dr. Amer Zeidan from Yale School of Medicine explains the uses, benefits, and risks of the newly approved treatment, Inqovi.

AAMDSIF Podcast for Patients:  MDS - Inqovi Treatment with Dr. Amer Zeidan

"Podcasts for Patients" from the Aplastic Anemia and MDS International Foundation features interviews with Bone Marrow Failure Specialists and Patients

For more, see our podcast page at:  https://www.aamds.org/podcast/

Treatment Options for MDS with Dr. Rory Shallis

AAMDSIF Podcasts for Patients

Related tracks